Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
5.84%
Price
08:01
?
Summary
This prediction is currently active. With a performance of 5.84%, the SELL prediction by Barclays_PLC for Hikma Pharmaceuticals is trending in the wrong direction Dividends of €0.41 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | -0.052% | -0.052% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat